Science & Tech

Russian Scientists Develop Drug That Targets Antibiotic-Resistant Bacteria

© Sputnik / Evgeniy Odinokov / Go to the mediabankEvaluation of Sputnik V Vaccine Effectiveness in the Gemotest Laboratory in Moscow, Russia
Evaluation of Sputnik V Vaccine Effectiveness in the Gemotest Laboratory in Moscow, Russia - Sputnik India, 1920, 22.11.2026
Subscribe
Specialists at the Gamaleya Research Center for Epidemiology and Microbiology have developed an agent against antibiotic-resistant strains of Klebsiella pneumoniae.
The drug works differently from conventional antibiotics by blocking the bacteria's ability to produce toxins, move, invade cells, and form biofilms, rather than killing them outright.
Klebsiella pneumoniae can cause severe pneumonia, bloodstream infections, and urinary tract infections, with fatality rates reaching 40% to 70%.
In the EU, bloodstream infections caused by this bacterium rose 72% between 2019 and 2025, medical data shows.
The development offers a way to counter resistance, since the danger comes not from the bacterium itself but from its strains that withstand standard treatment.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала